Arda Durmaz, Tim A D Henderson, Douglas Brubaker, Gurkan Bebek
{"title":"个性化信号通路网络的频繁子图挖掘将疾病通路频繁失调的患者分组,并预测预后。","authors":"Arda Durmaz, Tim A D Henderson, Douglas Brubaker, Gurkan Bebek","doi":"10.1142/9789813207813_0038","DOIUrl":null,"url":null,"abstract":"<p><strong>Motivation: </strong>Large scale genomics studies have generated comprehensive molecular characterization of numerous cancer types. Subtypes for many tumor types have been established; however, these classifications are based on molecular characteristics of a small gene sets with limited power to detect dysregulation at the patient level. We hypothesize that frequent graph mining of pathways to gather pathways functionally relevant to tumors can characterize tumor types and provide opportunities for personalized therapies.</p><p><strong>Results: </strong>In this study we present an integrative omics approach to group patients based on their altered pathway characteristics and show prognostic differences within breast cancer (p < 9:57E - 10) and glioblastoma multiforme (p < 0:05) patients. We were able validate this approach in secondary RNA-Seq datasets with p < 0:05 and p < 0:01 respectively. We also performed pathway enrichment analysis to further investigate the biological relevance of dysregulated pathways. We compared our approach with network-based classifier algorithms and showed that our unsupervised approach generates more robust and biologically relevant clustering whereas previous approaches failed to report specific functions for similar patient groups or classify patients into prognostic groups.</p><p><strong>Conclusions: </strong>These results could serve as a means to improve prognosis for future cancer patients, and to provide opportunities for improved treatment options and personalized interventions. The proposed novel graph mining approach is able to integrate PPI networks with gene expression in a biologically sound approach and cluster patients in to clinically distinct groups. We have utilized breast cancer and glioblastoma multiforme datasets from microarray and RNA-Seq platforms and identified disease mechanisms differentiating samples.</p><p><strong>Supplementary information: </strong>Supplementary methods, figures, tables and code are available at https://github.com/bebeklab/dysprog.</p>","PeriodicalId":49658,"journal":{"name":"Progress of Theoretical Physics","volume":"128 1","pages":"402-413"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029858/pdf/","citationCount":"0","resultStr":"{\"title\":\"FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING PATHWAY NETWORKS GROUPS PATIENTS WITH FREQUENTLY DYSREGULATED DISEASE PATHWAYS AND PREDICTS PROGNOSIS.\",\"authors\":\"Arda Durmaz, Tim A D Henderson, Douglas Brubaker, Gurkan Bebek\",\"doi\":\"10.1142/9789813207813_0038\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Motivation: </strong>Large scale genomics studies have generated comprehensive molecular characterization of numerous cancer types. Subtypes for many tumor types have been established; however, these classifications are based on molecular characteristics of a small gene sets with limited power to detect dysregulation at the patient level. We hypothesize that frequent graph mining of pathways to gather pathways functionally relevant to tumors can characterize tumor types and provide opportunities for personalized therapies.</p><p><strong>Results: </strong>In this study we present an integrative omics approach to group patients based on their altered pathway characteristics and show prognostic differences within breast cancer (p < 9:57E - 10) and glioblastoma multiforme (p < 0:05) patients. We were able validate this approach in secondary RNA-Seq datasets with p < 0:05 and p < 0:01 respectively. We also performed pathway enrichment analysis to further investigate the biological relevance of dysregulated pathways. We compared our approach with network-based classifier algorithms and showed that our unsupervised approach generates more robust and biologically relevant clustering whereas previous approaches failed to report specific functions for similar patient groups or classify patients into prognostic groups.</p><p><strong>Conclusions: </strong>These results could serve as a means to improve prognosis for future cancer patients, and to provide opportunities for improved treatment options and personalized interventions. The proposed novel graph mining approach is able to integrate PPI networks with gene expression in a biologically sound approach and cluster patients in to clinically distinct groups. We have utilized breast cancer and glioblastoma multiforme datasets from microarray and RNA-Seq platforms and identified disease mechanisms differentiating samples.</p><p><strong>Supplementary information: </strong>Supplementary methods, figures, tables and code are available at https://github.com/bebeklab/dysprog.</p>\",\"PeriodicalId\":49658,\"journal\":{\"name\":\"Progress of Theoretical Physics\",\"volume\":\"128 1\",\"pages\":\"402-413\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029858/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress of Theoretical Physics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1142/9789813207813_0038\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress of Theoretical Physics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1142/9789813207813_0038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
动机:大规模基因组学研究已经对许多癌症类型进行了全面的分子特征描述。许多肿瘤类型的亚型已经建立;然而,这些分类是基于小基因组的分子特征,在患者水平上检测失调的能力有限。我们假设,对通路进行频繁的图挖掘,收集与肿瘤功能相关的通路,可以确定肿瘤类型的特征,并为个性化治疗提供机会:在这项研究中,我们提出了一种综合omics方法,根据患者改变的通路特征对其进行分组,并显示出乳腺癌(p < 9:57E - 10)和多形性胶质母细胞瘤(p < 0:05)患者的预后差异。我们在二次 RNA-Seq 数据集中验证了这种方法,结果分别为 p < 0:05 和 p < 0:01。我们还进行了通路富集分析,以进一步研究失调通路的生物学相关性。我们将我们的方法与基于网络的分类器算法进行了比较,结果表明,我们的无监督方法生成的聚类更稳健、更具有生物学相关性,而之前的方法未能报告类似患者群体的特定功能或将患者分为预后组:这些结果可作为改善未来癌症患者预后的一种手段,并为改进治疗方案和个性化干预提供机会。所提出的新型图挖掘方法能够以一种符合生物学原理的方法整合 PPI 网络和基因表达,并将患者聚类为临床上不同的组别。我们利用来自微阵列和 RNA-Seq 平台的乳腺癌和多形性胶质母细胞瘤数据集,确定了区分样本的疾病机制:补充方法、图、表和代码可在 https://github.com/bebeklab/dysprog 上获取。
FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING PATHWAY NETWORKS GROUPS PATIENTS WITH FREQUENTLY DYSREGULATED DISEASE PATHWAYS AND PREDICTS PROGNOSIS.
Motivation: Large scale genomics studies have generated comprehensive molecular characterization of numerous cancer types. Subtypes for many tumor types have been established; however, these classifications are based on molecular characteristics of a small gene sets with limited power to detect dysregulation at the patient level. We hypothesize that frequent graph mining of pathways to gather pathways functionally relevant to tumors can characterize tumor types and provide opportunities for personalized therapies.
Results: In this study we present an integrative omics approach to group patients based on their altered pathway characteristics and show prognostic differences within breast cancer (p < 9:57E - 10) and glioblastoma multiforme (p < 0:05) patients. We were able validate this approach in secondary RNA-Seq datasets with p < 0:05 and p < 0:01 respectively. We also performed pathway enrichment analysis to further investigate the biological relevance of dysregulated pathways. We compared our approach with network-based classifier algorithms and showed that our unsupervised approach generates more robust and biologically relevant clustering whereas previous approaches failed to report specific functions for similar patient groups or classify patients into prognostic groups.
Conclusions: These results could serve as a means to improve prognosis for future cancer patients, and to provide opportunities for improved treatment options and personalized interventions. The proposed novel graph mining approach is able to integrate PPI networks with gene expression in a biologically sound approach and cluster patients in to clinically distinct groups. We have utilized breast cancer and glioblastoma multiforme datasets from microarray and RNA-Seq platforms and identified disease mechanisms differentiating samples.
Supplementary information: Supplementary methods, figures, tables and code are available at https://github.com/bebeklab/dysprog.